Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2024-03-08 00:00:00 ET · period of report 2024-03-06 · accession 0001765581-24-000038 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-08 | 2024-03-06+ | JAZZ | Carr Patricia | SVP, CAO | S - Sale | $118.37 | -3,704 | 8,364 | -31% | -$438.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-03-06 | S | D | 1,236 | $120.85 | 9,064 | D | — | — | |
| 2 | Common | Ordinary Shares | 2024-03-07 | S | D | 1,768 | $116.98 | 6,596 | D | — | — | (F2) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $116.93 to $117.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 3 | Common | Ordinary Shares | 2024-03-06 | S | D | 700 | $117.51 | 8,364 | D | — | — |